(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIFOLZA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

LIFOLZA

ST13

US500000079429331

Class

5

Filing

79429331

Registration

8131906

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

03/13/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

06/05/2025

Registration date

02/10/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/10/2026

Last transaction

03/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

85

Owner location

PT

Examiner

CORNWELL, ANDREA B

Law office

M60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

BIAL - R&D INVESTMENTS, S.A.

Representatives

No representative data.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products and preparations for the prevention and treatment of lysosomal storage disordersin particular Gaucher Diseaseas well as of diseases and disorders affecting the central and peripheral nervous systemsincluding movement disordersParkinson's diseaserelated parkinsonian conditions.

Publications

History of USPTO decisions and trademark events.

13 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/12/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/10/2026

PUBO

PUBLISHED FOR OPPOSITION

12/23/2025

GPNX

NOTIFICATION PROCESSED BY IB

12/18/2025

NPUB

NOTICE OF PUBLICATION

12/17/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/03/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/02/2025

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

11/18/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/29/2025

DOCK

ASSIGNED TO EXAMINER

10/24/2025

MAFR

APPLICATION FILING RECEIPT MAILED

08/07/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/07/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/07/2025

Continuous trademark protection

Get notified about every new filing that threatens LIFOLZA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.